Original research in The Lancet Infectious Diseases

Infections with Soil-Transmitted Helminths in BaAka Pygmies ... - MDPI

... article may be reused without permission provided that the original article is clearly cited. ... (This article belongs to the Special Issue Parasitic Diseases ...

The major COVID variants we've seen so far and which one to look ...

... infectious than the original strain of SARS-CoV-2. The CDC ... A study published in 2022 in The Lancet Infectious Diseases found ...

Peer review at The Lancet Infectious Diseases in 2023

With this issue of The Lancet Infectious Diseases, the editors of the journal would like to thank the 959 reviewers who submitted reports in 2023.

EQUATOR Network | Enhancing the QUAlity and Transparency Of ...

Your one-stop-shop for writing and publishing high-impact health research. Find reporting guidelines, improve your writing, join our courses, run your own ...

2024 Kilachand Fund Awards Boost Projects Building Antivirus ...

A 2022 analysis published in The Lancet reported ... BU's Leading Home for Infectious Diseases Research to Get Major Upgrade with NIH Grant.

Number of people globally with uncontrolled diabetes exceeds 445 ...

... study in the Lancet has warned. In the first global analysis of ... Infectious Diseases shows. 'I thought I'd be next': Working in the ...

The Lancet, 16 November 2024, Volume 404, Issue 10466, Pages ...

Non-communicable diseases: can implementation research change the game for policy and practice? ... first-in-human interventional study in Japan.

Blood Lancet Market Size, Share | CAGR Of 7.8%

infoThe graph presents a CAGR-based primary research forecast until 2032 or 2033. ... The rising prevalence of chronic and infectious diseases necessitates ...

One decade on - The Lancet Infectious Diseases

Our first IF, announced in 2005, of 10·788 put the journal at the top of the infectious diseases category and more than four points ahead of Antiviral Therapy ...

English - Google Scholar Metrics

28. International Journal of Environmental Research and Public Health ... The Lancet Infectious Diseases, 177, 334. 68. JAMA Network Open, 177, 267. 69. ACS ...

Medicine amidst genocide in Gaza: An interview with Bilal Irfan

When you think about maternal health care, as I mentioned in The Lancet ... infectious diseases like cholera, and then made projections about the ...

Research brief - The Lancet Infectious Diseases

Coronavirus risk to embryos · Hope for a global vaccine · A gift from cats · T cells for HIV therapy · Zika virus worsens dengue · Antibiotics and saliva microbes.

The November 2024 Research Roundup - First10EM

Lancet Child Adolesc Health. 2024 Jul;8(7):482-490. doi: 10.1016 ... first really promising result I have seen in a clinical trial so far.

Open access - The Lancet

Original research Articles are eligible for open access publishing in our ... The Lancet Infectious Diseases. USD 6,620. The Lancet Microbe *. USD 6,620.

Global impact of the first year of COVID-19 vaccination - The Lancet

Related Specialty Collections. This article can be found in the following collections: Infectious Diseases ...

A time for celebration - The Lancet Infectious Diseases

It was only in August, 2010, that original research articles were published for the first time, giving the journal the opportunity to present in its pages ...

Looking back and looking ahead - The Lancet Infectious Diseases

The October issue marks the first issue of The Lancet Infectious Diseases with our new Editor-in-Chief, Ursula Hofer, on the team.

Research in brief - The Lancet Infectious Diseases

Researchers characterised the population structure and genomic diversity of invasive meningococcal isolates in South Africa from 2016 to 2021. Using phenotypic ...

Online future of The Lancet Infectious Diseases review papers

When The Lancet Infectious Diseases was launched almost 14 years ago it was as a review journal. That situation changed in August, 2010, when the journal ...

The Lancet Infectious Diseases, September 2024, Volume 24, Issue ...

Articles · p953. p953. Temporal changes in SARS-CoV-2 clearance kinetics and the optimal design of antiviral pharmacodynamic studies: an individual patient data ...